Average cost of multi drug-resistant tuberculosis treatment in Venezuela, Bolivarian Republic of
Venezuela, Bolivarian Republic of: Average cost of multi drug-resistant tuberculosis treatment was 674 constant 2022 US$ in 2024. ◆ Volatile
Average cost of multi drug-resistant tuberculosis treatment in Venezuela, Bolivarian Republic of, 2017–2024
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
The most recent figure for average cost of multi drug-resistant tuberculosis treatment in Venezuela, Bolivarian Republic of is 674 constant 2022 US$, measured in 2024. That is the lowest value across all 8 years on record.
That represents a change of down 7.7% on the previous year and down 30.9% over ten years.
That places Venezuela, Bolivarian Republic of 70th out of 92 countries with data for 2024, putting it in the bottom quarter.
Average cost of multi drug-resistant tuberculosis treatment in Venezuela, Bolivarian Republic of, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2017 | 976 constant 2022 US$ | — |
| 2018 | 739 constant 2022 US$ | -24.3% |
| 2019 | 806 constant 2022 US$ | +9.1% |
| 2020 | 3,062 constant 2022 US$ | +279.9% |
| 2021 | 1,600 constant 2022 US$ | -47.7% |
| 2022 | 795 constant 2022 US$ | -50.3% |
| 2023 | 730 constant 2022 US$ | -8.2% |
| 2024 | 674 constant 2022 US$ | -7.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 840.33 constant 2022 US$ | 739 constant 2022 US$ | 976 constant 2022 US$ | 3 |
| 2020s | 1,372 constant 2022 US$ | 674 constant 2022 US$ | 3,062 constant 2022 US$ | 5 |
Countries ranked near Venezuela, Bolivarian Republic of
More health data for Venezuela, Bolivarian Republic of
- Un projection of annual infant deaths, annual growth rate -1.88 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.44 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,244 deaths per 1,000 people (2090)
- Number of infants who die before age 1 888 deaths (2100)
- Population ages 60-64, female, annual growth rate 1.73 % change on previous year (2025)
- Population ages 60-64, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 60-64, female, per capita 0.0246 units per person (2025)
- Population ages 60-64, male, annual growth rate 1.76 % change on previous year (2025)
- Population ages 60-64, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 60-64, male, per capita 0.0218 units per person (2025)
Frequently asked questions
- What is average cost of multi drug-resistant tuberculosis treatment in Venezuela, Bolivarian Republic of?
- Average cost of multi drug-resistant tuberculosis treatment in Venezuela, Bolivarian Republic of was 674 constant 2022 US$ in 2024, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of multi drug-resistant tuberculosis treatment recorded in Venezuela, Bolivarian Republic of?
- The highest recorded value was 3,062 constant 2022 US$ in 2020.
- What is the lowest average cost of multi drug-resistant tuberculosis treatment recorded in Venezuela, Bolivarian Republic of?
- The lowest recorded value was 674 constant 2022 US$ in 2024.
- How does Venezuela, Bolivarian Republic of rank for average cost of multi drug-resistant tuberculosis treatment?
- Venezuela, Bolivarian Republic of ranks 70th out of 92 countries with data for 2024.
- Is average cost of multi drug-resistant tuberculosis treatment rising or falling in Venezuela, Bolivarian Republic of?
- Over the last ten years it is down 30.9%. The long-run trend across the full record is volatile.
- Where does this Venezuela, Bolivarian Republic of data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of multi drug-resistant tuberculosis treatment. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 8 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.